Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736618 · ClinicalTrials.gov registry record
S-ICD® System Post Approval Study
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,766
- Enrollment target
NCT01736618 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,766 participants.
The verdict
NCT01736618 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,766 participants
- Enrollment target
Study Summary
The purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting.
Interventions
- DEVICE S-ICD System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,766 participants |
| Start Date | 2013-03-12 |
| Est. Completion | 2021-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01736618
The ClinicalTrials.gov registry entry for NCT01736618 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,766 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which S-ICD System is the first listed.
NCT01736618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01736618 about?
NCT01736618 is a clinical study titled "S-ICD® System Post Approval Study". The purpose of the S-ICD Post Approval Study is to document long term safety and effectiveness outcomes associated with the implantation of the SQ-RX pulse generator and Q-TRAK electrode in a commercial clinical setting.
What is the current status of trial NCT01736618?
This trial is currently completed. The enrollment target is 1,766 participants. The study started on 2013-03-12. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT01736618?
The interventions under investigation include: S-ICD System (DEVICE).
Who is sponsoring clinical trial NCT01736618?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.